Antiphospholipid Syndrome in Pregnancy

Rheumatic Disease Clinics of North America

Volumn 33, Issue 2, 2007, Pages 287-297

  Ruiz Irastorza, Guillermo ^a   Khamashta, Munther A ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; DALTEPARIN; ENDOTHELIN RECEPTOR ANTAGONIST; ENOXAPARIN; FONDAPARINUX; HEPARIN; HEPARIN CALCIUM; HIRUDIN; IMMUNOGLOBULIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; NIFEDIPINE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROSTACYCLIN DERIVATIVE; VITAMIN D; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; COMBINATION CHEMOTHERAPY; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; LOW DRUG DOSE; MONOTHERAPY; OSTEOPOROSIS; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; THROMBOSIS;

ABORTION, SPONTANEOUS; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HEPARIN; HUMANS; HYPERTENSION, PULMONARY; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; THROMBOSIS;

EID: 34248184556     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.02.003     Document Type: Review

References (56)

1. Branch D.W., and Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 101 (2003) 1333-1344
2. Opatrny L., David M., Kahn S.R., et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 33 (2006) 2214-2221
3. Erkan D., Merririll J.T., Yazici Y., et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 44 (2001) 1466-1467
4. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
5. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
6. Lackner K.J., Peetz D., and von Landenberg P. Revision of the Sapporo criteria for the antiphospholipid syndrome-coming to grips with evidence and Thomas Bayes?. Thromb Haemost 95 (2006) 917-919
7. Petri M., and Qazi U. Management of antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 32 (2006) 591-607
8. Stone S., Khamashta M.A., and Poston L. Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 10 (2001) 67-74
9. 2glycoprotein I. Arthritis Rheum 43 (2000) 140-150
10. Pierangeli S.S., Girardi G., Vega-Ostertag M., et al. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52 (2005) 2120-2124
11. Girardi G., Redecha P., and Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10 (2004) 1222-1226
12. Silver R.M., Porter T.F., van Leeuween I., et al. Anticardiolipin antibodies: clinical consequences of "low titers.". Obstet Gynecol 87 (1996) 494-500
13. Lima F., Khamashta M.A., Buchanan N.M.M., et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14 (1996) 131-136
14. Lynch A., Silver R., Emlen W., et al. Antiphospholipid antibodies in healthy pregnant women. Rheum Dis Clin North Am 23 (1997) 55-70
15. Empson M., Lassere M., Craig J., et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 18 2 (2005) CD002859
16. Lockshin M.D., Drunzin M., and Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 160 (1989) 439-443
17. Silver R.K., MacGregor S.N., Sholl J.S., et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169 (1993) 1411-1417
18. Cowchock F.S., Reece E.A., Balaban D., et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randimized trial comparing prednisone with low-dose heparin. Am J Obstet Gynecol 166 (1992) 1318-1323
19. Triolo G., Ferrante A., Ciccia F., et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48 (2003) 728-731
20. Branch D.W., Peaceman A.M., Druzin M., et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 182 (2000) 122-127
21. Rai R., Cohen H., Dave M., et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 314 (1997) 253-257
22. Farquharson R.G., Quenby S., and Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100 (2002) 408-413
23. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 (2002) 1019-1027
24. Granger K.A., and Farquharson R.G. Obstetric outcome in antiphospholipid syndrome. Lupus 6 (1997) 509-513
25. Huong D.L.T., Wechsler B., Bletry O., et al. A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 28 (2001) 2025-2030
26. Muñoz-Rodriguez F.J., Font J., Cervera R., et al. Clinical study of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 29 (1999) 182-190
27. Carmona F., Font J., Azulay M., et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am J Reprod Immunol 46 (2001) 274-279
28. Cowchock S., and Reece E.A. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial. Am J Obstet Gynecol 176 (1997) 1099-1100
29. Pattison N.S., Chamley L.W., Birdsall M., et al. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183 (2000) 1008-1012
30. Ruiz-Irastorza G., Nelson-Piercy C., and Khamashta M.A. Aspirin to treat obstetric manifestations of the antiphospholipid syndrome. [letter]. Am J Obstet Gynecol 185 (2001) 523-524
31. Noble L.S., Kutteh W.H., Lashey N., et al. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83 (2005) 684-690
32. Stephenson M.D., Ballem P.J., Tsang P., et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 26 (2004) 729-734
33. Bates S., Greer I.A., Hirsh J., et al. Use of antithrombotic agents during pregnancy. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 627S-644S
34. Tincani A., Branch W., Levy R.A., et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12 (2003) 524-529
35. Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R.V. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1 (2002) 298-304
36. Ruiz-Irastorza G., and Khamashta M.A. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 1051 (2005) 606-612
37. Wetzl R.G. Anestesiological aspects of pregnancy in patients with rheumatic diseases. Lupus 13 (2004) 699-702
38. Cuadrado M.J., Mendonça L.L.F., Khamashta M.A., et al. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. [abstract]. Arthritis Rheum 42 (1999) S265
39. Hunt B.J., Khamashta M.A., Lakasing L., et al. Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: is warfarin preferable?. Thromb Haemost 79 (1998) 1060-1061
40. Pauzner R., Dulitzki M., Lanevitz P., et al. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 86 (2001) 1379-1384
41. Ostensen M., Khamashta M., Lockshin M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209
42. Milne F., Redman C., Walker J., et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. Br Med J 330 (2005) 576-580
43. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br Med J 330 (2005) 565
44. Dekker G.A., de Vries J.I., Doelitzsch P.M., et al. Underlying disorders associated with severe early onset pre-eclampsia. Am J Obstet Gynecol 173 (1995) 1042-1048
45. Branch D.W., Andres R., Digre K.B., et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 73 (1989) 541-554
46. Ornstein M.H., and Rand J.H. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases. J Rheumatol 21 (1994) 1360-1364
47. Le Thi Thuong D., Tieulié N., Costedoat N., et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64 (2005) 273-278
48. Papageorghiou A.T., and Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol 17 (2005) 584-590
49. Nelson-Piercy C. Hypertension and pre-eclampsia. In: Nelso-Piercy C. (Ed). Handbook of obstetric medicine (1997), Isis medical media, Oxford (England) 1-16
50. Duley L., Henderson-Smart D., Knight M., et al. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. Br Med J 322 (2001) 329-333
51. Galie N., Manes A., Farahani K.V., et al. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14 (2005) 713-717
52. Bonnin M., Mercier F.J., Sitbon O., et al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102 (2005) 1133-1137
53. McMillan E., Martin W.L., Waugh J., et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus 11 (2002) 392-398
54. Ruiz-Irastorza G., Khamashta M.A., Nelson-Piercy C., et al. Lupus pregnancy: is heparin a risk factor for osteoporosis?. Lupus 10 (2001) 597-600
55. Kerslake S., Morton K.E., Versi E., et al. Early Doppler studies in lupus pregnancy. Am J Reprod Immunol 28 (1992) 172-175
56. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45 (2006) 332-338